Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Toxicology   Volumes    Volume 10 
Evaluation of toxicity, cytotoxicity and mutagenicity of an imidazole derivative on Allium cepa L.
Manoel Pinheiro Lucio Neto, Alisson Ferreira Dantas, Débora Cássia Vieira Gomes, Márcia Fernanda Correia Jardim Paz, Ana Maria Oliveira Ferreira da Mata, Marcus Vinícius Oliveira Barros de Alencar, Md. Torequl Islam, Ana Amélia de Carvalho Melo-Cavalcante
Pages: 71 - 77
Number of pages: 7
Current Topics in Toxicology
Volume 10 

Copyright © 2014 Research Trends. All rights reserved

The compound PT-31, 3-(2-cloro-6-fluorobenzil)-imidazolidine-2,4-dione, is a promising derivative of imidazolidine with proven agonist activity at the α2A-adrenergic receptors, that displays analgesic dose-dependent and synergistic action profile with morphine. This study evaluates the toxicity, cytotoxicity and mutagenicity of PT-31 on Allium cepa L. Three graded dosages with dilution ranging from 0.5 to 5.0 mg/mL were used in the present study, with dechlorinated water and copper sulphate (0.0006 mg/mL) as negative and positive controls, respectively. After 72 hours of exposure, the roots were measured and removed. Analyses of root growth and mitotic index were used to assess the toxicity and cytotoxicity. Mutagenicity was identified by the frequencies of chromosomal aberrations and of micronuclei. The PT-31 inhibited the mitotic index and root growth at a dose of 5.0 mg/mL (P < 0.001) and increased frequencies of chromosomal aberrations and micronuclei at a dose of 1.0 mg/mL (P < 0.05). These data indicate toxicity, cytotoxicity and mutagenicity of PT-31. Given the clinical potential of PT-31, we suggest additional studies to elucidate the mechanisms that generate the effects observed. The A. cepa test, as well as the Ames test, may be used for pre-clinical tests related to toxicity, cytotoxicity and mutagenicity, and may predict an initial profile of safety and efficacy of the new molecule.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms